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Abstract
Proteasomes (proteinase complexes, PR) and immunoproteasomes (IPR) degrade damaged proteins and aﬀect protein processing
required for antigen presentation by mononuclear phagocytes. These critical immune processes are attenuated during progressive
HIV-1 infection and are aﬀected by alcohol abuse. To investigate the mechanisms underlying these functional changes, we measured
PR and CYP2E1 activities [an ethanol (EtOH) metabolizing enzyme] and reactive oxygen species (ROS) in human monocyte-derived macrophages (MDM) following HIV-1 infection and EtOH treatment. We observed progressive declines of PR activity
and PR/IPR contents in HIV-1-infected MDM. PR activity and IPR expression increased after IFN-c stimulation but reduced after
HIV-1 infection. EtOH inhibited both IFN-c-induced PR and IPR. Paradoxically, EtOH attenuated PR catalytic activity in infected
MDM and suppressed viral replication. Elevated ROS followed EtOH exposure and paralleled decreased PR activity. The latter was
restored by anti-oxidant. The data support the notion that HIV-1 infection and EtOH may work in concert to aﬀect immune function including antigen presentation and thereby aﬀect disease progression.
 2004 Elsevier Inc. All rights reserved.
Keywords: Mononuclear phagocytes; CYP2E1; Reactive oxygen species; Antigen presentation

1. Introduction
Alcohol abuse can aﬀect the progression of HIV-1 disease [1,2]. Acute and chronic alcohol abuse impairs a
broad range of immune functions and thus is implicated
as a cofactor in HIV-1 infection. Nonetheless, the mechanisms by which alcohol aﬀects the HIV-1 cellular targets
are unknown. Ethanol (EtOH) exposure leads to diminished T- and B-lymphocyte numbers, immunoglobulin
and pro-inﬂammatory cytokine [tumor necrosis factor
*
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(TNF)-a, interleukin (IL)-1b, and IL-6] production
[3–6]. EtOH can also aﬀect antigen presentation by macrophages and dendritic cells [7], phagocytosis [8] and
intracellular killing [9]. Macrophage activation induced
by lipopolysaccharide is attenuated after EtOH administration [10]. EtOH induces secretion of anti-inﬂammatory
factors (transforming growth factor b and prostaglandin
E2) [1,11,12]. Acute EtOH intoxication can also suppress
inﬂammatory responses in normal subjects through inhibition of accessory function and leukocyte migration
[10,13–15]. In simian immunodeﬁciency virus (SIV)-infected animals EtOH suppresses TNF-a and leads to increased susceptibility to secondary infections [16].
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Degradation of damaged or short-lived regulatory
proteins is a function of the proteasome (PR). The PR
consists of a 20S catalytic core that is activated by binding of the PA28 regulator [17–19]. PR constitutive
subunits (X, Y, Z) possess chymotrypsin-like (X), trypsin-like (Y), and peptidyl-glutamyl-peptide hydrolase
(Z) activities [20,21]. PR activity is up-regulated by
pro-inﬂammatory cytokines [interferon (IFN)-c TNF-a
and IL-6] [20,22]. After IFN-c stimulation, constitutive
PR subunits X, Y, and Z are replaced by inducible PR
subunits LMP2, LMP7, and MELC-1 [20,21]. Processing of protein antigens within inducible subunits of
IPR is important in subsequent conjugation with the
class I major histocompatibility complex (MHC) required for antigen presentation [21,23]. While no data
are available to suggest that alcohol aﬀects PR function
in antigen presenting cells (APC), studies performed
using liver cells point to PR impairment as a result of
exposure to EtOH or its metabolites [24].
Microsomal enzymes belonging to the cytochrome
P450 family catalyze a variety of hydroxylation reactions. Cytochrome P450 2E1 (CYP2E1) is a terminal
oxidase in the microsomal respiratory chain and is involved in EtOH metabolism [25]. Monocyte-derived
macrophages (MDM) and rat liver macrophages express
CYP2E1 [26,27]. CYP2E1 plays a central role in EtOH
metabolism by macrophages [28]. Inhibition of
CYP2E1, attenuated EtOH-induced reduction of PR
activities in vivo, in liver cells [29,30]. Such eﬀects are assumed to be associated with increased production of
reactive oxygen species (ROS). We now hypothesize that
EtOH may aﬀect PR function and in doing so aﬀect
antigen presentation. We demonstrate that both HIV-1
infection and EtOH diminish PR activity and IPR contents in macrophages and thus, may contribute to immune dysfunction in an infected human host.

2. Materials and methods

cell-free macrophage-tropic strain HIV-1ADA inoculum
(4 · 105 cpm/106 cells) standardized for all experiments
by reverse transcriptase (RT) activity [32]. RT activity
was determined in triplicate in culture ﬂuids after addition of 0.05% Nonidet P-40 (Sigma), 10 lg/ml poly(A),
0.25 lg/ml oligo(dt) (Pharmacia Fine Chemicals, Piscataway, NJ), and 5 mM dithiothreitol thymidine 5 0 -triphosphate (2 Ci/mmol; Amersham, Arlington Heights,
IL) in Tris–HCl buﬀer (pH 7.9) for 24 h at 37 C. Radiolabeled nucleic acids were precipitated with cold 10%
trichloroacetic acid (TCA) and 95% EtOH in an automatic cell harvester (Packard Instrument Company,
Meriden, CT) on paper ﬁlters. Radioactivity was estimated by liquid scintillation spectroscopy. Level of
infection was also assessed in MDM (3, 5, and 9 days
after infection) by staining for HIV-1 p24 [using primary
monoclonal antibodies (Abs) from Dako, Carpenteria,
CA, detected by avidin–biotin immunoperoxidase, Vectastain Elite ABC kit, Vector Laboratories, Burlingame,
CA]. Immunostained cells were analyzed with a Nikon
Microphot-FXA microscope. RT results were normalized to viable cell numbers determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
assay [33]. Brieﬂy, after collecting the culture media
from HIV-1 infected MDM in 96-well plate for RT, cells
were incubated with MTT (5 mg/ml solution of 10%
FBS in PBS) for 45 min at 37 C. Reduction of MTT
to formazan was assessed at 490 nm using plate reader.
2.2. Cell treatments
After treating MDM with 25 mM EtOH, ethanol concentration in culture ﬂuids was determined by using EtOH
assay kit (Diagnostic Chemicals Limited, P.E.I. Canada).
This was done to assay possible evaporation of EtOH
after 8, 24, and 48 h incubation at 37 C. EtOH recovery
was 95–98% when compared to the start concentration.
MDM were stimulated with IFN-c (10 ng/ml, R&D Systems, Minneapolis, MN) in order to mimic immune activation in HIV-1 infected cells and to induce IPR.

2.1. Isolation and virus infection of human monocytederived macrophages

2.3. Protein extraction

Human monocytes were isolated from HIV-1, 2, and
hepatitis B seronegative donors and puriﬁed by countercurrent centrifugal elutriation [31]. Monocytes were cultured at 30 · 106 cells/T75 ﬂask in 10 ml in DulbeccoÕs
modiﬁed EagleÕs medium (Sigma Chemical, St. Louis,
MO) with 10% heat inactivated human serum, 1%
glutamine, 50 lg/ml gentamicin (Sigma), 10 lg/ml ciproﬂoxacin (Sigma), and 1000 U/ml human macrophage
colony-stimulating factor (a generous gift from Genetics
Institute, Cambridge, MA). In parallel, monocytes were
cultured in 96-well plates for viability assays at 105 cells/
well in 100 ll media for seven days, changing the medium every third day. MDM then were infected with

After 48 h treatment period, media was aspirated
from T75 culture ﬂasks, followed by two successive
washes with ice-cold 20 mM phosphate buﬀered saline.
Cells were scraped into 1 ml ice-cold extraction buﬀer
(50 mM Tris–HCl, pH 7.5, containing 20% glycerol,
5 mM ATP, 5 mM MgCl2, and 0.5 mM DTT). After sonicating the cell suspension on ice, a 300 ll lysate aliquot
was stored from each sample without the protease inhibitor for the analysis of PR chymotrypsin-like activity
and for the immunoblots of PR and IPR. Before subjecting to denaturing electrophoresis under non-reducing conditions, lysates were centrifuged at 14,000 rpm
(15,000g) for 15 min at 4 C. Lysates then were
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centrifuged at 35,000 rpm (105,000g) for 1 h at 4 C to
sediment the microsome fraction for CYP2E1 assay.
2.4. PR Chymotrypsin-like activity
Chymotrypsin-like activity was assayed using 7-amino-4-methylcoumarin as the standard and N-succinyl-LEU-LEU-VAL-TYR-7-amino-4-methylcoumarin
(LLVY assay) as the ﬂuorogenic peptide substrate (Sigma). Chymotrypsin-like activity was assayed in 96-well
plates containing 40 lM LLVY substrate and 20 ll sample lysate in a reaction mixture of 50 ll in 0.2 M Tris–
HCl, pH 7.4, either in the presence or absence of
0.03% sodium dodecyl sulfate (SDS). Experimental samples and appropriate controls were set up in triplicate
and incubated for 1 h at 37 C. The reaction was stopped
by adding 190 ll of 0.1 M Tris–HCl, pH 9.1, and 60 ll of
1% SDS to each well. The ﬂuorescence was measured at
390 nm excitation and 440 nm emission.
2.5. CYP2E1 activity
CYP2E1 activity was determined by the hydroxylation of p-nitrophenol to 4-nitrocatechol catalyzed by
CYP2E1 following an established method [27]. Reaction
mixtures of 50 ll containing 2 mM b-nicotinamide adenine dinucleotide phosphate and 0.8 mM p-nitrophenol
(both from Sigma) were added to 1.5 ml microcentrifuge
tubes containing 50 ll of microsomal suspension in triplicate on ice. Blank tubes of identical composition were
prepared except that 20% TCA was added prior to the
reaction mixture on ice. The reactions were terminated
by adding 30 ll of 20% TCA immediately after 1 h incubation at 37 C in a water bath shaker. After 15 min, the
sample and blank tubes were centrifuged for 10 min at
14,000 rpm to remove insoluble proteins. Supernatants
were transferred to 96-well plate and 10 ll of 10 N
NaOH were added for color development. The absorbance was read at 540 nm in the 96-well Vmax kinetic
reader (Molecular Devices). CYP2E1 activity from
MDM microsome was calculated using 4-nitrocatechol
(Sigma) as the internal standard. CYP2E1 activity was
expressed as nmol/mg protein.
2.6. Western blot analyses
Western blotting was performed as previously described [34]. Brieﬂy, 10 lg lysate protein was loaded onto
1.5 mm thick 4–15% gradient polyacrylamide precast gels
(Bio-Rad, Hercules, CA) those were electrophoresed under denatured non-reducing conditions. Proteins from
the gels were transblotted onto nitrocellulose membranes
(0.45 lm pore size) at 60 V for 1 h at 24 C. The membranes were blocked with superblock (Bio-Rad) containing 2% nonfat dry milk for 40 min at 24 C. Blots were
incubated for 1 h at 24 C with the respective primary
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antibody in superblock solution that was 10-fold diluted
with 20 mM phosphate buﬀer saline, pH 7.4, containing
0.1% Tween 20 (PBST), followed by three successive
washes with PBST for 5 min. Immunoreactive bands
were detected by luminol detection kit (Pierce, Rockford,
IL) followed by exposure to Kodak X-ray ﬁlm. The
bands were quantiﬁed densitometrically as arbitrary volume integration units using the Molecular Dynamics
ImageQuant software (Sunnyvale, CA). Results were expressed as the ratio of the density of the target protein
immunoreactivity to that of the internal standard a-actin
immunoreactivity (which was not aﬀected by EtOH
treatment, HIV-1 infection or IFN-c). The following
Abs were used for Western blot: polyclonal Abs to 20S
and 19S, monoclonal Abs to LMP2 or LMP7 (all from
Aﬃnity Research Products, Mamhead, UK), polyclonal
Abs to CYP2E1 (Research Diagnostic, Flander, NJ),
and monoclonal Abs to 3-nitrotyrosine (Upstate Cell
Signaling Solutions, Lake Placid, NY).
2.7. ROS detection by the dichloroﬂuorescein diacetate
assay
Dichloroﬂuorescein diacetate (DCF-DA) (an indicator for ROS) is non-ﬂuorescent until the acetate groups
are removed by intracellular esterases and then oxidation
occurs within the cell [35]. DCF-DA is converted to highly
ﬂuorescent DCF by cellular peroxides. The ﬂuorescence is
detected at excitation 488 nm and at emission 525 nm
using a ﬂuorescence plate reader. Sample mixtures contained 10 ll of cell lysate, 50 ll of DCF-DA (Molecular
Probes, Eugene, OR) and 140 ll of distilled water and
incubated at 37 C for 15 min followed by the detection
of ﬂuorescence. The blank mixtures contained 50 ll of
methanol instead of 50 ll of DCF-DA. The intensity values of the blanks were subtracted from the experimental
sample intensity values. The results were expressed as speciﬁc mean ﬂuorescence intensity per mg protein.
2.8. Statistical analyses
The signiﬁcance of the eﬀects of HIV-1, EtOH, and
IFN-c on PR activity, CYP2E1 activity, ROS production, and expression of PR/IPR, CYP2E1 and 3-nitrotyrosine were assessed using two-way ANOVA with
Newman–Keuls post-test for multiple comparisons. A
p value of < 0.05 was considered signiﬁcant.

3. Results
3.1. HIV-1 infection decreases PR activity and PR/IPR
content in MDM
We ﬁrst investigated the eﬀect of MDM diﬀerentiation on the PR chymotrypsin-like activity. This increased
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13-fold from day one after monocyte isolation
(1.13 ± 0.17 nmol/mg protein) through day nine
(14.82 ± 0.19 nmol/mg protein), followed by a plateau
phase (data not shown). HIV-1 infection of MDM resulted in 8–43% decline in the chymotrypsin-like activity
3–9 days after infection (Fig. 1A), while the normalized
RT activity increased 6.5 times from days 3 to 9 post-infection (1509, 7593, and 9800 cpm RT activity, respectively, for days 3, 5, and 9 post-infection). A negative
correlation was observed between level of RT activity
and PR activity (correlation coeﬃcient; r = 0.804,
p < 0.01) in HIV-1-infected MDM. The percentage of infected MDM at days 3, 5, and 9 were 3, 38, and 85%,
respectively, as determined by HIV-1 p24 immunostain-

ing. A modest decrease in cell viability of HIV-1 infected
MDM (17–20%) was detected at 3–9 days post-infection
when compared to uninfected cells. The decline in PR
activity was not due to cell death by HIV-1 infection, because each sample was extracted only from viable adherent MDM and all assays were performed in samples
adjusted by protein content. Treatment of lysates from
uninfected MDM with the 20S PR activator 0.03%
SDS [36], resulted in 4-fold increase of activity indicating
high levels of 20S PR. HIV-1-infected MDM demonstrated only 2-fold increase in PR activity in the presence
of SDS, pointing to the impaired function of 20S by
HIV-1 infection in MDM (data not shown).
These functional changes paralleled expression of PR
subunits detected by Western blot assays. HIV-1-infected MDM showed a 20% (20S) and 26% (19S) decrease
when compared with uninfected cells (p < 0.001) (Fig.
1B). Expression of LMP2 and LMP7 subunits of IPR
diminished by 30 and 24% (p < 0.001), respectively
(Fig. 1B), indicating that viral infection negatively affected IPR content in MDM. These results indicate a
speciﬁc eﬀect of HIV-1 infection on PR function/expression in MDM. These may not be attributed to HIV-induced changes in cell viability, because equal amount
of protein was loaded from each sample for immunoblots and results were further normalized to internal
standard (a-actin). Thus, decreased of PR/IPR activity
and expression in HIV-1 infected MDM are related to
the levels of HIV-1 infection and replication.
3.2. Eﬀects of IFN-c on PR activity and PR/IPR content
in MDM

Fig. 1. Eﬀects of HIV-1 infection on chymotrypsin-like activity and
proteasome content in MDM. (A) Chymotrypsin-like activity was
measured in HIV-1-infected MDM at days 3, 5, and 9 post-infection.
We used 7-amino-4-methylcoumarin as an internal standard and Nsuccinyl-LEU-LEU-VAL-TYR-7-amino-4-methylcoumarin (LLVY)
as a ﬂuorogenic peptide substrate for the PR activity assay. Fluorescence was measured at 390 nm (excitation) and 440 nm (emission).
LLVY activity was expressed in nmol/mg protein. (B) Content of 20S
constitutive PR, 19S regulatory (ATPase dependent) subunit of 26S
PR, LMP2, and LMP7 subunits of IPR were measured in uninfected
or infected MDM at day 9 post-infection. Results were expressed as
the ratio of target protein immunoreactivity to that of internal
standard a-actin. Values obtained from HIV-1 uninfected MDM were
used as controls (normalized to a value of 100%). Each bar was derived
from mean value of four replicates ± SEM. Data were statistically
analyzed using two-way ANOVA with Newman–Keuls post-test.
Representative data from four experiments performed with independent MDM donors are shown.

To mimic immune activation in HIV-1 infected cells,
replicate infected or uninfected MDM were stimulated
with IFN-c (10 ng/ml). IFN-c up-regulated chymotrypsin-like activity in MDM (199%, p < 0.001) and HIV-1
MDM (218%, p < 0.001) (Fig. 2A). Despite IFN-c treatment PR activity was 60% lower in infected as compared
to uninfected IFN-c stimulated MDM. IFN-c treatment
had no eﬀect on cell viability (data not shown), IFN-c
treatment did not alter the levels of 20S or 19S PR in
both infected and uninfected MDM when compared to
unstimulated cells (Fig. 2B). Contrary to the ﬁndings
for constitutive PR, the levels of LMP2 and LMP7
(Fig. 2C) in IFN-c-treated MDM were elevated by 29
and 27% when compared to non-treated cells
(p < 0.001). Similarly, IFN-c treatment increased levels
of LMP2 and LMP7 by 28 and 17% in HIV-1-infected
MDM (p < 0.001). In agreement with catalytic activity,
expression of IPR was lower in virus-infected and
IFN-c-treated MDM (LMP2, 46% and LMP7, 43%,
p < 0.001) when compared to IFN-c-treated uninfected
MDM. These results suggest that a major increase in
PR activity seen after IFN-c stimulation is associated
with IPR but not constitutive PR subunits.
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demonstrated that MDM viability or PR activity was
not changed after 48 h treatment with 0.25–25 mM
EtOH (data not shown). Cell viability was adversely affected by EtOH concentrations higher than 25 mM (data
not shown). Although addition of 25 mM EtOH did not
change chymotrypsin-like activity in uninfected MDM
(Fig. 3), it decreased PR activity (by 25%, p < 0.001)
up-regulated by IFN-c to the levels seen in unstimulated
cells (Fig. 3). Similar to the functional changes, EtOH
decreased the levels of IFN-c-induced IPR, LMP2,
and LMP7 by 22% in EtOH/IFN-c-treated MDM as
compared to IFN-c stimulated MDM (p < 0.001, Figs.
4A and B), while expression of 20S and 19S was not altered by EtOH treatment in uninfected cells (Figs. 4C
and D). Exposure of infected MDM to EtOH prevented
decrease of chymotrypsin-like activity by 7% (p < 0.05,
day 3, data not shown), 18% (p < 0.02, day 5, data not
shown), and 31% (p < 0.001, day 9 post-infection, Fig.
3, bars 3 and 7). Opposite to results seen in uninfected
cells, chymotrypsin-like activity in IFN-c-stimulated
HIV-1-infected MDM with EtOH treatment was moderately higher (10%) as compared to IFN-c stimulated
HIV-1-infected MDM without EtOH exposure
(p < 0.01; Fig. 3, bars 4 and 8). The contents of both
constitutive PR and IPR were not changed after EtOH
treatment of infected MDM as compared to untreated
cells without IFN-c stimulation (Figs. 4A–D).
To establish whether EtOH had dose-dependent effects on PR activity, infected MDM were treated with
varied concentrations of EtOH (0.25, 2.5, and 25 mM)
for 8, 24, 48, and 72 h. All concentrations of EtOH
had a protective eﬀect on chymotrypsin-like activity in
infected cells (Fig. 5). Treatment with EtOH (0.25–
25 mM) for 48 h decreased RT activity by 26–33%
(p < 0.01) (Fig. 5). These eﬀects on PR activity were

Fig. 2. Eﬀects of IFN-c on proteasome activity and level of expression
in MDM. (A) Changes in the proteasomal catalytic activity in MDM
(day 9 post-infection) after 48 h stimulation with IFN-c. (B) Content of
20S constitutive PR, 19S regulatory (ATPase dependent) subunit of
26S PR, and (C) LMP2 and LMP7 subunits of IPR were measured in
uninfected or infected MDM at day 9 post-infection treated for 48 h
with IFN-c. Results were expressed as the ratio of target protein
immunoreactivity to that of internal standard a-actin. Values obtained
from HIV-1 uninfected and IFN-c untreated MDM were used as a
controls (normalized to a value of 100%). Each bar was derived from
mean value of four replicates ± SEM. Data were statistically analyzed
using two-way ANOVA with Newman–Keuls post-test. Representative data from four experiments performed with independent MDM
donors are shown.

3.3. Eﬀects of EtOH on PR activity and PR/IPR content
in MDM
MDM were treated with 25 mM EtOH. The concentration used was based on our initial experiments, which

Fig. 3. Eﬀects of EtOH on chymotrypsin-like activity in MDM.
Changes in the proteasomal catalytic activity in MDM at day 9 postinfection after 48 h stimulation with IFN-c with or without simultaneous
EtOH treatment. Values represent the mean of four determinations ± SEM. Data were statistically analyzed using two-way ANOVA
with Newman–Keuls post-test. Representative data from four experiments performed with independent MDM donors are shown.
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Fig. 4. Eﬀects of EtOH on proteasome expression in MDM. Changes in the proteasome expression in MDM (day 9 post-infection) after 48 h
stimulation with IFN-c with or without simultaneous EtOH treatment. Results were expressed as the ratio of target protein immunoreactivity to that
of internal standard, actin. Values obtained from HIV-1 uninfected and IFN-c untreated MDM were used as a controls (normalized to a value of
100%). (A) Ratio of LMP2/actin, (B) LMP7/actin, (C) 20S/actin, and (D) 19S/actin. Each bar was derived from mean value of four
replicates ± SEM. Data were statistically analyzed using two-way ANOVA with Newman–Keuls post-test. Representative data from four
experiments performed with independent MDM donors are shown.

Fig. 5. Eﬀects of EtOH concentrations on chymotrypsin-like activity and virus replication in HIV-1-infected MDM. Changes in PR and RT
activities in HIV-1 infected MDM at day 9 post-infection after 8, 24 or 48 h treatment without or with diﬀerent EtOH concentrations. Results
obtained from HIV-1 infected MDM without EtOH treatment are indicated by ‘‘EtOH’’ and with EtOH treatment indicated by ‘‘+EtOH.’’ The bar
graphs represent the PR activity (left Y axis) and the line graphs above the bars show the RT activity (right Y axis). Values are the mean of four
determinations ± SEM. Data were statistically analyzed using two-way ANOVA with Newman–Keuls post-test. Representative data from four
experiments performed with independent MDM donors are shown.

inversely proportional to the levels of HIV-1 replication.
Uninfected cells treated with 25 mM EtOH and/or INFc served as positive controls (data not shown). As ex-

pected, treatment of uninfected MDM with EtOH did
not change PR activity, and INF-c treatment up-regulated PR activity.

J. Haorah et al. / Cellular Immunology 229 (2004) 139–148

In summary, EtOH inhibited both INF-c-induced
IPR activity and increased IPR expression in uninfected
MDM. EtOH decreased HIV-1 replication in infected
MDM and ameliorated virus-induced decrease in PR
activity. Inhibiting eﬀects of EtOH on HIV-1 replication
and IFN-c-induced PR activity led to slight increase in
PR activity in EtOH treated/IFN-c stimulated infected
MDM.
3.4. EtOH metabolism by CYP2E1 leads to ROS
production in MDM
CYP2E1 is suggested to be a major pathway for
EtOH metabolism in MDM [37]. To further conﬁrm this
ﬁnding, we studied CYP2E1 enzyme activity in MDM.
While modest CYP2E1 activity was found in uninfected
MDM, it was increased by EtOH (1.8 fold, p < 0.001).
However, levels of CYP2E1 activity were signiﬁcantly
lower in HIV-1-infected MDM (25–50%), and were enhanced with EtOH treatment (2-fold) (Fig. 6A). HIV-1
infection resulted in 30% diminution of CYP2E1 content
detected by Western blot assays in MDM (Fig. 6B).
EtOH treatment up-regulated CYP2E1 content in both
uninfected (3.3-fold) and infected MDM (2.6-fold) as
compared to replicate untreated controls. These changes
were comparable with alterations in functional activity
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(Fig. 6A). Treatment with IFN-c did not change
CYP2E1 expression in infected or uninfected cells (data
not shown).
Since it is known that CYP2E1 activity is associated
with oxygen radical production [38], we tested generation of ROS in MDM after EtOH exposure by DCF
ﬂuorescence assay. EtOH exposure signiﬁcantly increased ROS (10–23% increase in ﬂuorescence intensity, p < 0.001) and this eﬀect was less prominent in
HIV-1-infected MDM (8–10%), proportional to decreased activity of CYP2E1 (p < 0.001) (Fig. 6C). These
data were substantiated by Western blot detection of
215 kDa nitrated protein, an established marker of peroxynitrite oxidation [39]. As positive controls we used
three nitrated proteins of molecular weight 16 kDa (nitrated bovine superoxide dismutase), 66 kDa (nitrated
bovine serum albumin) and 215 kDa (nitrated rabbit
muscle myosin). The level of 215 kDa nitrated protein
was signiﬁcantly lower in HIV-1-infected MDM as
compared to uninfected cells (36%, p < 0.001, Fig.
6D). EtOH treatment caused a 23% increase in nitrotyrosine content in uninfected MDM (p < 0.01) but it
had no eﬀect on its level in HIV-1-infected MDM
(Fig. 6D). The expression levels of two nitrated proteins with lower molecular weight were very low in
MDM.

Fig. 6. Eﬀects of HIV-1 infection, IFN-c and EtOH on CYP2E1 activity and content, ROS and their modulation by an antioxidant: (A) CYP2E1
activity (nmol/mg protein) in uninfected or HIV-1 infected MDM (9 day post-infection) after 48 h EtOH treatment (25 mM). (B) CYP2E1 content
determined by Western blots using polyclonal anti-human CYP2E1. Data are expressed as ratio of denstitometric units for intensity of CYP2E1 to aactin. (C) DCF ﬂuorescence was measured in identical MDM donors as speciﬁc mean ﬂuorescence intensity per milligram protein. (D) Western blots
analyses determined 215 kDa nitrated protein immunoreactive species. Relative intensity was expressed as the ratio of nitrated protein to that of aactin band intensity. (E) Chymotrypsin-like activity (LLVY) was assayed in MDM treated with 25 mM EtOH or IFN-c (10 ng/ml) for 48 h followed
by 1 h incubation with 100 lM uric acid. Data were statistically analyzed using two-way ANOVA with Newman–Keuls post-test. Representative data
from four experiments with four independent MDM donors are shown.
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Next, we determined whether ROS generated
through CYP2E1 EtOH metabolism may lead to IPR
dysfunction in MDM. In order to test this premise, we
used a mild anti-oxidant, 100 lM uric acid. Its application did not change PR activity in MDM, but it was able
to restore chymotrypsin-like activity induced by IFN-c
and down regulated by EtOH to control levels (Fig.
6E). These results indicate that MDM exposure to
EtOH increased CYP2E1 activity and expression, and
EtOH metabolism by CYP2E1 led to ROS generation.
ROS inhibited IPR activity in MDM. HIV-1 infected
MDM demonstrated decreased activity/expression of
CYP2E1 and less ROS production after EtOH
treatment.

4. Discussion
This work sought to analyze the eﬀects of EtOH and
HIV-1 infection on PR function and on expression of
PR/IPR in MDM. EtOH metabolism by CYP2E1 leads
to ROS generation and may be responsible for IPR
impairment in MDM. IPR seems to be susceptible to
ROS generated via ethanol metabolism, because EtOH
prevented IFN-c-stimulated eﬀects on PR activity and
IPR content in MDM. Anti-oxidant reversed the eﬀect
of EtOH on IPR. HIV-1 infection decreased PR activity
and PR/IPR content as well as CYP2E1 activity and
expression. EtOH diminished viral replication attenuating inhibitory eﬀect of HIV-1 on PR activity. CYP2E1
activity was decreased in HIV-1-infected cells resulting

Fig. 7. Schematic representation of possible mechanistic pathway
derived from the present ﬁndings. EtOH induces CYP2E1 activity in
uninfected MDM, which in turn metabolizes EtOH, leading to
generation of ROS and subsequent decrease in IRP expression and
function (shown on left ﬂow chart). Infection of MDM with HIV-1
down regulates PR function and expression of PR/IPR (shown on
right ﬂow chart). Both EtOH and HIV-1 impair IPR in MDM and
may result in ineﬃcient antigen presentation.

in less eﬃcient EtOH metabolism by virus-infected cells
and the absence of signiﬁcant alterations in IPR activity
already down regulated by viral infection (Fig. 7).
Similar to the ﬁndings reported for PR expression
during maturation of dendritic cells [40], we found a signiﬁcant increase in chymotrypsin-like activity during
MDM diﬀerentiation (from days 3 to 9 in culture). In
dendritic cells, this increase in PR activity was associated with a synthetic switch from constitutive PR to
IPR [40]. Importantly, we found that diﬀerentiated
MDM expressed high levels of IPR even without IFNc stimulation. Chymotrypsin-like activity decline in
HIV-1 infected MDM was directly proportional to the
level of virus replication. Decrease of PR activity in
HIV-1-infected MDM was accompanied by diminished
expression of PR and IPR as compared to uninfected
MDM. This HIV-1 related decline in activity and
expression may be associated with Tat-induced (transcriptional transactivator of HIV-1) PR malfunction
[41,42].
Immune response against viral or bacterial infection
activates the PR regulator PA28 a/b, thereby substituting constitutive subunits of PR with IPR subunits
(LMP2, LMP7, and MELC-1) [21]. Indeed, IFN-c upregulated PR activity in MDM and HIV-1-infected
MDM; however, PR activity was lower in infected cells
even after IFN-c treatment as compared to MDM.
While IFN-c had no eﬀect on PR level, it increased
LMP2/LMP7 expression in MDM indicating that major
increase in PR activity after IFN-c stimulation is associated with IPR. Similar to catalytic activity, IPR expression was lower in HIV-1 infected and IFN-c stimulated
MDM when compared to IFN-c-treated uninfected
MDM. Since HIV-1 alters catalytic activities of PR
and expression of PR/IPR, these changes may interfere
with processing of MHC class I antigens resulting in impaired antigen presentation. Thus, viral replication may
negatively regulate elimination of infected cells by cytotoxic T lymphocytes.
Next, we examined the eﬀects of EtOH on PR function and PR/IPR expression in MDM. EtOH treatment
did not aﬀect the activity or expression of PR in uninfected MDM, but it attenuated both IFN-c-induced
PR activity (predominantly associated with IPR) and
enhanced LMP2/LMP7 expression in MDM. Currently,
EtOH-induced inhibition of PR activity was demonstrated only in liver tissue derived from EtOH-fed rats
and mice [29,43] and in hepatoma cell lines treated with
EtOH (HepG2) [44]. In vivo studies suggest more prominent impairment of 26S rather than 20S PR with EtOH
treatment. While dysfunction of 26S PR leads to ineﬃcient degradation of short-lived abnormal proteins by
the ubiquitin-PR pathway, EtOH-induced impairment
of IPR in MDM found in this study may potentially result in impaired antigen presentation. In uninfected
cells, EtOH not only diminished PR activity, but also
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decreased the levels of LMP2 and LMP7 content induced by IFN-c stimulation. It was shown that LMP2
and LMP7 deﬁcient mice had reduced CD8+T lymphocyte numbers and impaired antigen presentation [45,46].
EtOH-elicited IPR impairment observed for the ﬁrst
time in APC could underlie immunosuppressive eﬀects
of alcohol abuse [47].
Ethanol even at a low concentration protected the PR
catalytic activity in HIV-1-infected MDM, possibly
through suppression of virus replication. This protective
eﬀect of EtOH was not seen in the expression of 20S/19S
or LMP2/LMP7 in infected MDM after EtOH treatment as compared as compared to HIV-1-infected
MDM without EtOH exposure. However, it is not clear
if this protection is an in vitro phenomenon, or if it exists in vivo in HIV patients with alcoholics.
Contrary to results seen in uninfected MDM, EtOH
did not decrease PR activity up-regulated by IFN-c
stimulation in HIV-1-infected MDM. This might be related to diﬀerences in EtOH metabolism in HIV-1-infected versus uninfected MDM. Thus, we examined
activity and expression of CYP2E1 for EtOH metabolism in MDM. EtOH treatment resulted in increased
CYP2E1 activity and expression in MDM, whereas
HIV-1 infection reduced CYP2E1 activity and expression. Although CYP2E1 expression was demonstrated
before in macrophages [26,48], this is the ﬁrst report
analyzing eﬀects of EtOH and HIV-1 on CYP2E1 activity and expression in human MDM. The CYP2E1-mediated EtOH metabolism pathway leads to production of
ROS [49] and superoxide anions in human macrophages
[50]. Indeed, we detected higher levels of ROS in EtOH
treated MDM, but found only a modest increase in
HIV-1 MDM. These results closely paralleled activity
and expression of CYP2E1. Detection of signiﬁcantly
higher levels of nitrotyrosine in uninfected EtOH treated
MDM as compared to infected MDM under identical
conditions further substantiated our observations. The
absence of a signiﬁcant increase of ROS after EtOH
treatment in HIV-1 infected MDM may explain why
IPR activity was not altered in infected cells after alcohol exposure. It was shown that IPR are more susceptible to ROS-mediated inhibition compared with
constitutive PR [39]. Indeed, we were able to completely
restore the IPR activity in EtOH-treated and IFN-c
stimulated MDM by anti-oxidant.
In summary, the present study demonstrates that
HIV-1 infection modulates function and expression of
PR and IPR in APC. We found signiﬁcant induction
of CYP2E1 by EtOH treatment of uninfected MDM
resulting in the enhanced production of ROS and decrease in IRP expression and function. IPR dysfunction
could partially underlie immunosuppression observed in
alcoholics or HIV-1-infected patients leading to defective antigenic peptide processing. Furthermore, our results indicate beneﬁcial eﬀects of anti-oxidants.
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